| Literature DB >> 32460017 |
Xin Jin1, Wenxia Zhang1, Yang Wang1, Jia Liu1, Fengqi Hao1, Yunlong Li1, Miaomiao Tian1, Hengyao Shu1, Jiaxin Dong1, Yunpeng Feng2, Min Wei3.
Abstract
Dendritic cells (DCs) play a central role in both innate and adaptive immunity. Emerging evidence has demonstrated metabolic reprogramming during DC activation. However, how DC activation is linked with metabolic reprogramming remains unclear. Here we show that pyruvate kinase M2 (PKM2), the rate-limiting enzyme in the last step of glycolysis, is critical for LPS-induced DC activation. Upon DC activation, JNK signaling stimulated p300 association with PKM2 for the acetylation of lysine 433, a classic posttranslational modification critical for PKM2 destabilization and nuclear re-localization. Subsequently, nuclear PKM2 partnered with c-Rel to enhance Il12p35 expression, which is important for Th1 cell differentiation. Meanwhile, decreased enzymatic activity of PKM2 due to detetramerization facilitated glycolysis and fatty acid synthesis, helping DCs meet their need for biomacromolecules. Together, we provide evidence for metabolic control of DC activation and offer insights into aberrant immune responses due to dysregulated Th1 functions.Entities:
Keywords: IL-12; JNK; K433 acetylation; PKM2; dendritic cell
Mesh:
Substances:
Year: 2020 PMID: 32460017 DOI: 10.1016/j.celrep.2020.107690
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423